|
Common symptoms
|
How bad it is |
What people are taking for it |
- Severity
- Severe
- Moderate
- Mild
- None
|
|
Pain
|
-
59 (22%) patients experienced severe severity
-
90 (34%) patients experienced moderate severity
-
52 (20%) patients experienced mild severity
-
64 (24%) patients experienced no severity
|
Tramadol, Meloxicam, Hydrocodone-Acetaminophen
|
|
Insomnia
|
-
44 (17%) patients experienced severe severity
-
70 (27%) patients experienced moderate severity
-
67 (25%) patients experienced mild severity
-
82 (31%) patients experienced no severity
|
Trazodone, Amitriptyline, Zolpidem
|
|
Fatigue
|
-
66 (25%) patients experienced severe severity
-
100 (38%) patients experienced moderate severity
-
73 (28%) patients experienced mild severity
-
26 (10%) patients experienced no severity
|
Vitamin B Complex, Duloxetine, Vitamin B12 (cyanocobalamin)
|
|
Anxious mood
|
-
24 (9%) patients experienced severe severity
-
76 (29%) patients experienced moderate severity
-
82 (31%) patients experienced mild severity
-
81 (31%) patients experienced no severity
|
Clonazepam, Alprazolam, Diazepam
|
|
Depressed mood
|
-
28 (11%) patients experienced severe severity
-
84 (32%) patients experienced moderate severity
-
74 (28%) patients experienced mild severity
-
76 (29%) patients experienced no severity
|
Duloxetine, Fluoxetine, Citalopram
|
| Treatments reported by members |
Perceived effectiveness |
Overall rating of side effects |
# of Evaluations |
Atorvastatin
(Zarator, Lipitor, Atorsave F, Apo-Atorvastatin)
|
-
3 (75%) experienced major perceived effectiveness
-
0 (0%) experienced moderate perceived effectiveness
-
0 (0%) experienced slight perceived effectiveness
-
0 (0%) experienced no perceived effectiveness
-
|
-
0 (0%) experienced severe side effects
-
2 (50%) experienced moderate side effects
-
0 (0%) experienced mild side effects
-
2 (50%) experienced no side effects
|
4 |
|
|
-
1 (25%) experienced major perceived effectiveness
-
1 (25%) experienced moderate perceived effectiveness
-
1 (25%) experienced slight perceived effectiveness
-
0 (0%) experienced no perceived effectiveness
-
|
-
0 (0%) experienced severe side effects
-
0 (0%) experienced moderate side effects
-
0 (0%) experienced mild side effects
-
4 (100%) experienced no side effects
|
4 |
|
|
-
0 (0%) experienced major perceived effectiveness
-
2 (100%) experienced moderate perceived effectiveness
-
0 (0%) experienced slight perceived effectiveness
-
0 (0%) experienced no perceived effectiveness
-
|
-
1 (50%) experienced severe side effects
-
0 (0%) experienced moderate side effects
-
0 (0%) experienced mild side effects
-
1 (50%) experienced no side effects
|
2 |
| <20 |
20s |
30s |
40s |
50s |
60s |
70+ |
| Current Age |
|
|
|
|
|
|
|
|
Distribution of females vs. males
| Gender |
| 66% |
Females |
| 34% |
Males |
Age at first symptom
| Age at first symptom |
# of patients |
Proportion |
|
0-19 years
|
4 |
|
|
20-29 years
|
16 |
|
|
30-39 years
|
24 |
|
|
40-49 years
|
21 |
|
|
50-59 years
|
7 |
|
|
60-69 years
|
0 |
|
|
70+ years
|
0 |
|
Diagnosis status
| Diagnosis status |
# of patients |
Proportion |
|
Diagnosed
|
190 |
|
|
Not Diagnosed
|
12 |
|
Last updated: